NCT02929121View on ClinicalTrials.gov

A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India

PHASE3CompletedINTERVENTIONAL

Enrollment

235

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

June 18, 2021

Study Completion Date

June 18, 2021

Conditions

LymphedemaLymphatic FilariasisFilariasis

Interventions

DRUG

Doxycycline

Once daily tablet for 6 weeks: Doxycycline hyclate 200 mg per day x 6 weeks for patients \>50 kg or 100 mg per day for patients \<50 kg)

DRUG

Placebo

Once daily tablet for 6 weeks: matching tablets containing no active ingredients

Trial Locations (1)

688005

Filariasis Research Unit Govt. T. D. Medical College Hospital, Alappuzha

All Listed Sponsors

collaborator

United States Agency for International Development (USAID)

FED

lead

The Task Force for Global Health

OTHER

NCT02929121 - A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India | Biotech Hunter | Biotech Hunter